| D00503 | |
| D number | D00503 |
| Classification | Drug |
| Name | Perphenazine (JP17/USP/INN); Trilafon (TN) |
| Component | - |
| Formula | C21H26ClN3OS |
| Exact mass | 403.1485 |
| Mol weight | 403.9686 |
| Structural formula |  |
| Sequence | - |
| Sequence type | - |
| Source | - |
| Upper DGroup | Neuropsychiatric agent DG01905 Phenothiazine antipsychotics DG01478 Dopamine antagonist DG01474 Dopamine D2-receptor antagonist Cyp substrate DG01644 CYP2D6 substrate Cyp inhibitor DG01645 CYP2D6 inhibitor |
| Remark | Same as: C07427 Therapeutic category: 1172 ATC code: N05AB03 Chemical group: DG00875 |
| Activity | - |
| Disease | - |
| Comment | Phenothiazine derivative |
| Target | DRD2 [HSA:1813] [KO:K04145] |
| Metabolism | Enzyme: CYP2D6 [HSA:1565] |
| Interaction | Genomic biomarker: CYP2D6 [HSA:1565] |
| Other DBs | CAS: 58-39-9 PubChem: 7847569 ChEBI: 8028 ChEMBL: CHEMBL567 DrugBank: DB00850 LigandBox: D00503 NIKKAJI: J1.387K |
| KCF data | - |